Julio Ortiz
Chilpancingo C.P. 39090
Chilpancingo, GRO 39090, Mexico
Chilpancingo, GRO 39090, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.
Journal: Frontiers in bioscience (Landmark edition)
Published: February 25, 2026
Bioinformatic Analysis of Contrasting Expression Patterns and Molecular Interactions of TIMPs in Breast Cancer: Implications for Tumor Progression and Survival.
Journal: Pathophysiology : the official journal of the International Society for Pathophysiology
Published: December 14, 2025
Let-7c/RUNX1 Axis Promotes Cervical Cancer: A Bioinformatic Analysis.
Journal: Current issues in molecular biology
Published: July 25, 2025
Exometabolome and Molecular Signatures Associated with HPV 16 in Cervical Cancer: Integrative Metabolomic and Transcriptomic Analysis for Biomarker Discovery.
Journal: Molecules (Basel, Switzerland)
Published: July 24, 2025
Regulatory Genetic Networks by microRNAs: Exploring Genomic Signatures in Cervical Cancer.
Journal: Biomedicines
Published: March 03, 2025
Identification of ZNF384 as a regulator of epigenome in leukemia.
Journal: Leukemia research
Published: November 13, 2024
Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1α Axis.
Journal: Current issues in molecular biology
Published: May 02, 2024
TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers.
Journal: European review for medical and pharmacological sciences
Published: February 20, 2024
TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets.
Journal: International journal of molecular sciences
Published: November 24, 2023
Expression of HIF-1α and Genes Involved in Glucose Metabolism Is Increased in Cervical Cancer and HPV-16-Positive Cell Lines.
Journal: Pathogens (Basel, Switzerland)
Published: November 14, 2022
EMMPRIN is an emerging protein capable of regulating cancer hallmarks.
Journal: European review for medical and pharmacological sciences
Published: October 05, 2022
Last Updated: 09/26/2026